Skip to main content
Siddhartha Ganguly, MD, Hematology, Houston, TX, Houston Methodist Hospital

SiddharthaGangulyMDFACP

Hematology Houston, TX

Hematologic Oncology

Associate Director for Clinical Investigation and Research Chief, Division of Hematology. Houston Methodist Hospital and Neal Cancer Center, Houston, TX

Dr. Ganguly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ganguly's full profile

Already have an account?

  • Office

    6445 Main Street
    Outpatient Center, Floor 24
    Houston, TX 77030
    Phone+1 713-441-9948
    Fax+1 713-441-8791
  • Is this information wrong?

Summary

  • Dr. Siddhartha Ganguly is a hematologist in Houston, TX and is affiliated with Houston Methodist Hospital. He received his medical degree from Medical College and Hospital Kolkata and has been in practice for over 30 years. He specializes in hematologic oncology and is experienced in bone marrow transplantation, multiple myeloma, lymphoma, and cellular immunotherapy. He has more than 150 publications and over 500 citings. He has been PI for many clinical trials and is the Associate Director for Clinical Investigation at the Houston Methodist Hospital and Neal Cancer Center.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1994 - 1995
  • Southern Illinois University
    Southern Illinois UniversityInternship, Internal Medicine, 1993 - 1994
  • Medical College and Hospital Kolkata
    Medical College and Hospital KolkataClass of 1987
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Hematology

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1999 - Present
  • TX State Medical License
    TX State Medical License 2020 - 2024
  • KS State Medical License
    KS State Medical License 1995 - 2024
  • WA State Medical License
    WA State Medical License 1995 - 2010
  • IL State Medical License
    IL State Medical License 1993 - 1996
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2007
  • Outstanding Teacher Award University of Kansas Medical Center, 2005
  • Max S. Allen Clinical Scholar Award University of Kansas Medical Center, 2004
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Erythropoietin modulation is associated with improved homing and engraftment post umbilical cord blood transplantation  
    Aljitawi OS, Paul S, Ganguly A, Lin TL, Ganguly S, Vielhauer G, Capitano ML, Cantelina A, Lipe B, Mahnken JD, Wise A, Berry A, Singh AK, Shune L, Lominska C, Abhyankar..., Blood, 1/19/2016
  • Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors  
    Abraham S. Kanate, Alberto Mussett, Mohamed A. Kharfan-Dabaja, Kwang W. Ahn, Alyssa DiGilio,Amer Beitinjaneh , Saurabh Chhabra, Timothy S. Fenske, Cesar Freytes, Rober..., Blood, 1/18/2016
  • Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies  
    Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, G..., Biol Blood Marrow Transplant, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Effect of Co-Mutations and FLT3-ITD Variant Allele Frequency (VAF) on Response to Quizartinib or Salvage Chemotherapy (SC) in Relapsed/Refractory (R/R) Acute Myeloid L...
    Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Characterization of Response and Transfusion Independence in Patients with FLT3-Internal Tandem Duplication (FLT3-ITD)_Mutated Relapsed/Refractory Acute Myeloid Leukem...
    Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Preclinical Evaluation of Gilteritinib on NPM1-ALK Driven Anaplastic Large Cell Lymphoma Cells
    Siddhartha Ganguly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Disparities in Multiple Myeloma Care in Rural America 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Immunotherapy and targeted therapy 
    Joplin, MO - 1/28/2016
  • Join now to see all

Other

  • Cytogenetics in Hematology 
    Siddhartha Ganguly
    1/1/2014
  • Bone Marrow Transplant Algorithm and Standard Operating Procedure 
    Siddhartha Ganguly
    1/1/2011
  • Blood and Lymph Module, Formative and Summative quiz, PBL, Small Group Discussion 
    Siddhartha Ganguly
    1/1/2009
  • Join now to see all

Press Mentions

  • WJMSC‐Derived Small Extracellular Vesicle Enhance T Cell Suppression Through PD‐L1
    WJMSC‐Derived Small Extracellular Vesicle Enhance T Cell Suppression Through PD‐L1February 8th, 2021

Professional Memberships

Hospital Affiliations